Back
Ultragenyx Pharmaceutical Vs. BioNTech SE Industry Stock Comparison
Sell
47
RARE
Ultragenyx Pharmaceutical
Last Price:
59.07
Seasonality Move:
-0.7%
Buy
52
BNTX
BioNTech SE
Last Price:
111.01
Seasonality Move:
12.7%
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $57.70. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
BioNTech SE (BNTX)
is a Buy
Is BioNTech SE a Buy, Sell or Hold?
- The current BioNTech SE [BNTX] share price is $115.62. The Score for BNTX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- BNTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $57.70
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
BNTX Stock Price Chart
What is BioNTech SE's stock price today?
-
The BioNTech SE share price today is $115.62
The current trend is moderately bullish and BNTX is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.92 | Buy |
Relative Strength Index (14 RSI): | 62.1 | Buy |
Chaikin Money Flow: | -317060 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.11 - 58.13) | Buy |
Bollinger Bands (100): | (39.69 - 52.61) | Buy |
BNTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.77 | Buy |
Relative Strength Index (14 RSI): | 70.24 | Buy |
Chaikin Money Flow: | -1842663 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (82.95 - 108.15) | Buy |
Bollinger Bands (100): | (81.16 - 99.5) | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.5 | Buy |
20-day SMA: | 56.99 | Buy |
50-day SMA: | 51.17 | Buy |
200-day SMA: | 46.32 | Buy |
8-day EMA: | 57.7 | Sell |
20-day EMA: | 56.22 | Buy |
50-day EMA: | 52.28 | Buy |
200-day EMA: | 46.62 | Buy |
BNTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 111.6 | Buy |
20-day SMA: | 97.65 | Buy |
50-day SMA: | 89.56 | Buy |
200-day SMA: | 93.09 | Buy |
8-day EMA: | 112.27 | Buy |
20-day EMA: | 101.76 | Buy |
50-day EMA: | 93.73 | Buy |
200-day EMA: | 94.71 | Buy |
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
BioNTech SE Earnings Growth & BNTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.72 per share, an increase next quarter of $0.10 per share, a decrease this year of $7.38 per share, and a decrease next year of $0.37 per share.
Ultragenyx Pharmaceutical Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
BioNTech SE Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |